Danaher launches AI-powered autonomous lab to speed antibody discovery up to 8x faster.

Danaher Corporation announced the launch of its first AI-powered autonomous lab, expected to operate at scale in early 2027. The lab combines AI, robotics, and technologies from Danaher's companies to accelerate the development of custom antibodies and molecular tools, aiming to speed discovery up to eight times faster and increase reagent production tenfold. This innovation integrates continuous testing and learning to improve quality without sacrificing speed, marking a significant step toward smarter, more efficient scientific research workflows. The lab is part of Danaher's broader initiative to create connected, AI-enabled instruments and autonomous labs that enhance biomedical research and discovery.

Danaher Corporation's stock shows a modest gain, trading at USD 216.51 with a 0.44% increase on the day. As of Oct 07, 2026 18:11 WIB, the company holds a market cap of $151.57 billion on Pluang, reflecting steady investor interest amid its innovation in AI-powered labs.